Spots Global Cancer Trial Database for COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

Official Title: COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

Study ID: NCT01610531

Conditions

Patients at Risk for Melanoma

Interventions

SAMScore questionnaire

Study Description

Brief Summary: Melanoma is nowadays an important public health problem because its growing incidence. Mass screening for melanoma is not recommended worldwide because of its low cost-effectiveness. Nevertheless targeted screening for patients at high risk for melanoma is promoted. This study is designed to assess the effectiveness and the acceptability of a melanoma targeted screening of melanoma, to estimate the risk function to develop a melanoma among patients at high risk according to the SAMScore and to estimate the ratio cost/ efficacy of the melanoma targeted screening. A cohort of 7700 patients is carried out in 2 departments covered by a registry of cancers. The recruitment had began in April 2011. Patients assessed at high risk according to the SAMScore were proposed a skin examination by their GP every year.

Detailed Description: